Objective To evaluate the efficacy of physiotherapy for urinary manifestations in patients with
human T-lymphotropic virus 1–associated lower urinary tract dysfunction. Methods Open …

Aim: To evaluate the efficacy of the onabotulinum toxin type A in the treatment of HTLV-1
associated overactive bladder and its impact on quality of life (QoL). Methods: Case series …

Introduction HTLV‐I associated tropical spastic paraparesis (TSP) and HTLV‐I associated
myelopathy (HAM) is an endemic disease in Caribbean Island. Bladder‐sphincter …

OBJECTIVE: To compare neurological symptoms and signs in HTLV-1 asymptomatic
carriers and HTLV-1 patients with overactive bladder (OB) syndrome. METHODS: We …

OBJECTIVES: To describe the frequency of urologic manifestations in human T-cell
lymphotropic virus type I (HTLV-I) seropositive individuals from Salvador and other cities in …

Background While bladder dysfunction is observed in the majority of patients with human T
cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy (HAM), it is also observed in …

The majority of patients infected with human T‐cell lymphotropic virus‐type 1 (HTLV‐1) are
considered carriers, but a high frequency of urinary symptoms of overactive bladder …

Background HTLV-I infected patients often complain of urinary symptomatology.
Epidemiological studies have suggested that these individuals have a higher prevalence …

OBJECTIVES: To determine the prevalence of erectile dysfunction (ED) in human T-cell
lymphotropic virus type I (HTLV-I)-infected patients, and its association with overactive …

Objectives: The HTLV-1 is a retrovirus that causes several diseases, including tropical
spastic paraparesis or HTLV-1 associated myelopathy (or TSP/HAM, as designated by the …